Literature DB >> 21826515

Acute left ventricular failure in a patient with hydroxychloroquine-induced cardiomyopathy.

M Hartmann1, I L Meek, G K van Houwelingen, H P C M Lambregts, G J Toes, A C van der Wal, C von Birgelen.   

Abstract

We present the case of a 75-year-old woman with a medical history of rheumatoid arthritis treated with hydroxychloroquine, who was admitted with acute left-sided heart failure due to a hydroxychloroquine-induced cardiomyopathy as supported by endomyocardial biopsy.

Entities:  

Year:  2011        PMID： 21826515      PMCID： PMC3203986          DOI： 10.1007/s12471-011-0185-2

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  5 in total

Review 1.  Cardiomyopathy related to antimalarial therapy with illustrative case report.

Authors:  Nathalie Costedoat-Chalumeau; Jean-Sebastien Hulot; Zahir Amoura; Annick Delcourt; Thierry Maisonobe; Richard Dorent; Nicolas Bonnet; Régis Sablé; Philippe Lechat; Bertrand Wechsler; Jean-Charles Piette
Journal:  Cardiology       Date:  2006-06-22       Impact factor: 1.869

Review 2.  Histological and ultrastructural findings in chloroquine-induced cardiomyopathy.

Authors:  C August; H J Holzhausen; A Schmoldt; R Pompecki; S Schröder
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

Review 3.  Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.

Authors:  Jessica E Nord; Prediman K Shah; Renee Z Rinaldi; Michael H Weisman
Journal:  Semin Arthritis Rheum       Date:  2004-04       Impact factor: 5.532

4.  New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.

Authors:  T Rinda Soong; Lili A Barouch; Hunter C Champion; Frederick M Wigley; Marc K Halushka
Journal:  Hum Pathol       Date:  2007-12       Impact factor: 3.466

5.  Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease.

Authors:  James M Roos; Marie-Christine Aubry; William D Edwards
Journal:  Cardiovasc Pathol       Date:  2002 Sep-Oct       Impact factor: 2.185
  5 in total
  5 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.

Authors:  Emer Joyce; Aurelie Fabre; Niall Mahon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

Review 3.  Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.

Authors:  Romain Muller
Journal:  Rheumatol Int       Date:  2021-04-24       Impact factor: 2.631

Review 4.  Hydroxychloroquine in COVID-19 Patients: Pros and Cons.

Authors:  Nour K Younis; Rana O Zareef; Sally N Al Hassan; Fadi Bitar; Ali H Eid; Mariam Arabi
Journal:  Front Pharmacol       Date:  2020-11-19       Impact factor: 5.810

5.  Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19.

Authors:  Georgi Fram; Dee D Wang; Kelly Malette; Pedro Villablanca; Guson Kang; Kent So; Mir B Basir; Arfaat Khan; John E McKinnon; Marcus Zervos; William W O'Neill
Journal:  Curr Cardiol Rev       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.